Tejabhiram Yadavalli

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 20

Top Venues

Science advances

Microorganisms

Viruses

Nature communications

University of Illinois at Chicago

SRM University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Illinois at Chicago Apr 01 2016

United States

Post Doctoral Fellow :: Ophthalmology and Visual Sciences

Education History

SRM University Sep 01 2009 - Feb 19 2016

India

PHD :: Nanotechnology Research Centre

Publications

Rahul K Suryawanshi, Chandrashekhar D Patil, Alex Agelidis, Raghuram Koganti, Tejabhiram Yadavalli, Joshua M Ames, Hemant Borase, Deepak Shukla
Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction. Science advances 9 (17) (2023)
Rahul K Suryawanshi, Chandrashekhar D Patil, Alex Agelidis, Raghuram Koganti, Tejabhiram Yadavalli, Joshua M Ames, Hemant Borase, Deepak Shukla
Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction. Science advances 9 (17) (2023)
Rahul K Suryawanshi, Chandrashekhar D Patil, Alex Agelidis, Raghuram Koganti, Tejabhiram Yadavalli, Joshua M Ames, Hemant Borase, Deepak Shukla
Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction. Science advances 9 (17) (2023)
Rahul K Suryawanshi, Chandrashekhar D Patil, Alex Agelidis, Raghuram Koganti, Tejabhiram Yadavalli, Joshua M Ames, Hemant Borase, Deepak Shukla
Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction. Science advances 9 (17) (2023)
Rahul K Suryawanshi, Chandrashekhar D Patil, Alex Agelidis, Raghuram Koganti, Tejabhiram Yadavalli, Joshua M Ames, Hemant Borase, Deepak Shukla
Pathophysiology of reinfection by exogenous HSV-1 is driven by heparanase dysfunction. Science advances 9 (17) (2023)
Tejabhiram Yadavalli, Pankaj Sharma, David Wu, Divya Kapoor, Deepak Shukla
CREB3 Plays an Important Role in HPSE-Facilitated HSV-1 Release in Human Corneal Epithelial Cells. Viruses 14 (6) (2022)
Ilina Bhattacharya, Tejabhiram Yadavalli, David Wu, Deepak Shukla
Plasma Membrane-Derived Liposomes Exhibit Robust Antiviral Activity against HSV-1. Viruses 14 (4) (2022)
Pradeep Chopra, Apoorva Joshi, Jiandong Wu, Weigang Lu, Tejabhiram Yadavalli, Margreet A Wolfert, Deepak Shukla, Joseph Zaia, Geert-Jan Boons
The 3-O-sulfation of heparan sulfate modulates protein binding and lyase degradation. Proceedings of the National Academy of Sciences of the United States of America 118 (3) (2021)
Tejabhiram Yadavalli, Ipsita Volety, Deepak Shukla
Aptamers in Virology-A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy. Pharmaceutics 13 (10) (2021)
Joshua Ames, Tejabhiram Yadavalli, Rahul Suryawanshi, James Hopkins, Alexander Agelidis, Chandrashekhar D Patil, Brian Fredericks, Henry C Tseng, Tibor Valyi-Nagy, Deepak Shukla
OPTN is a host intrinsic restriction factor against neuroinvasive HSV-1 infection. Nature communications 12 (1) (2021)
Yogesh Sutar, Tejabhiram Yadavalli, Sagar Kumar Paul, Sudipta Mallick, Raghuram Koganti, Harsh Chauhan, Abhijit A Date, Deepak Shukla
BX795-Organic Acid Coevaporates: Evaluation of Solid-State Characteristics, In Vitro Cytocompatibility and In Vitro Activity against HSV-1 and HSV-2. Pharmaceutics 13 (11) (2021)
Rahul K Suryawanshi, Chandrashekhar D Patil, Alexander Agelidis, Raghuram Koganti, Joshua M Ames, Lulia Koujah, Tejabhiram Yadavalli, Krishnaraju Madavaraju, Lisa M Shantz, Deepak Shukla
mTORC2 confers neuroprotection and potentiates immunity during virus infection. Nature communications 12 (1) (2021)
Chandrashekhar D Patil, Rahul K Suryawanshi, Joshua M Ames, Raghuram Koganti, Alex Agelidis, Divya Kapoor, Tejabhiram Yadavalli, Lulia Koujah, Henry C Tseng, Deepak Shukla
Intrinsic Antiviral Activity of Optineurin Prevents Hyperproliferation of a Primary Herpes Simplex Virus Type 2 Infection. Journal of immunology (Baltimore, Md. : 1950) (2021)
David Wu, Raghuram Koganti, Upendra P Lambe, Tejabhiram Yadavalli, Shyam S Nandi, Deepak Shukla
Vaccines and Therapies in Development for SARS-CoV-2 Infections. Journal of clinical medicine 9 (6) (2020)
Tejabhiram Yadavalli, Rahul Suryawanshi, Raghuram Koganti, James Hopkins, Joshua M Ames, Lulia Koujah, Aqsa Iqbal, Krishnaraju Madavaraju, Alex Agelidis, Deepak Shukla
Standalone or combinatorial phenylbutyrate therapy shows excellent antiviral activity and mimics CREB3 silencing. Science advances 6 (49) (2020)
Tejabhiram Yadavalli, Joshua M Ames, Alex Agelidis, Rahul Suryawanshi, Dinesh Jaishankar, James Hopkins, Neel Thakkar, Lulia Koujah, Deepak Shukla
Drug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery. Science advances 5 (8) (2019)
Dinesh Jaishankar, Abraam M Yakoub, Tejabhiram Yadavalli, Alex Agelidis, Neel Thakkar, Satvik Hadigal, Joshua M Ames, Deepak Shukla
An off-target effect of BX795 blocks herpes simplex virus type 1 infection of the eye. Science translational medicine 10 (428) (2019)
Monique Munro, Tejabhiram Yadavalli, Cheryl Fonteh, Safa Arfeen, Ann-Marie Lobo-Chan
Cytomegalovirus Retinitis in HIV and Non-HIV Individuals. Microorganisms 8 (1) (2019)
Raghuram Koganti, Tejabhiram Yadavalli, Deepak Shukla
Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections. Microorganisms 7 (10) (2019)
Neel Thakkar, Tejabhiram Yadavalli, Dinesh Jaishankar, Deepak Shukla
Emerging Roles of Heparanase in Viral Pathogenesis. Pathogens (Basel, Switzerland) 6 (3) (2017)

Tejabhiram Yadavalli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tejabhiram Yadavalli